Ananda Developments Plc - Notice of AGM PR Newswire

ANANDA DEVELOPMENTS PLC

(“Ananda” or the “Company”)

Notice of AGM

Ananda Developments plc announces that the Company has sent notice to shareholders convening the Company’s annual general meeting, to be held at the offices of Shakespeare Martineau LLP, 6th Floor, 60 Gracechurch Street, London EC3V 0HR on 31st July 2019 at 11.00 am.

The directors of the Company accept responsibility for the contents of this announcement.

--ENDS—


Ananda Developments plc           +44 (0)20 7520 9266
CEO                               ir@anandadevelopments.com
Melissa Sturgess

Investor Relations
Jeremy Sturgess-Smith

Peterhouse Capital Limited        +44 (0)20 7469 0930
Corporate Finance
Fungai Ndoro
Mark Anwyl

Corporate Broker
Lucy Williams
Duncan Vasey

Stanford Capital Partners Limited +44 (0)20 3815 8880
Joint Corporate Broker
John Howes
Patrick Claridge

Celicourt Communications
Mark Antelme
Ollie Mills



Notes to editors

About Ananda Developments PLC

Ananda Developments invests in the developing market for medical or therapeutic Cannabis derivatives, or related products, including but not limited to nutraceuticals, dietary supplements and cosmetic products which contain Cannabis or hemp derived cannabinoids. The Directors believe that this market is growing due to an increasing number of states in the USA, as well as other countries around the world, changing their laws to allow for products containing constituents of Medical Cannabis to be developed, approved and sold.

A copy of the Company’s Admission Document is available at www.anandadevelopments.com/wp-content/uploads/2019/03/ANANDA-DEVELOPMENTS-Admission-Document-29.06.2018-FINAL-clean.pdf

Ananda’s investment strategy is to invest in companies, projects or products that are progressing medical or therapeutic Cannabis research and development, or seeking to produce or cultivate Cannabis in any jurisdiction in which it is legal to do so, or are developing or have already developed, products that contain Cannabis derived cannabinoids and require funding to progress work plans or commercialise products.

http://www.anandadevelopments.com